Tousignant Jennifer bought VRDN
March 2, 2026 · Form 4 insider transaction
Tousignant Jennifer bought 119,300 shares of Viridian Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
119,300
Price
$0.00
Total value
N/A
InsiderTousignant Jennifer
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after119,300
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests and becomes exercisable in 48 equal monthly installments following the date of the grant, subject to the Reporting Person's continued service to Issuer through each vesting date. The date of the grant is March 2, 2026.